4.8 Article

pcMSC Modulates Immune Dysregulation in Patients With COVID-19-Induced Refractory Acute Lung Injury

Related references

Note: Only part of the references are listed.
Review Microbiology

Characteristics of SARS-CoV-2 and COVID-19

Ben Hu et al.

Summary: This review summarizes the research progress on SARS-CoV-2 and COVID-19, including virology characteristics, pathogenesis, and recent advances in treatment methods. Furthermore, it discusses in detail the potential wildlife hosts and zoonotic origin of this emerging virus.

NATURE REVIEWS MICROBIOLOGY (2021)

Article Biochemistry & Molecular Biology

Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19

Lauren B. Rodda et al.

Summary: The study found that individuals recovered from mild COVID-19 develop sustained SARS-CoV-2-specific immunological memory for at least 3 months, including immunoglobulin antibodies, neutralizing plasma, and memory B and T cells. These memory lymphocytes exhibit potent antiviral function, aiding in immune defense.
Article Multidisciplinary Sciences

Correlates of protection against SARS-CoV-2 in rhesus macaques

Katherine McMahan et al.

Summary: Adoptive transfer of purified IgG from convalescent macaques protects naive macaques against SARS-CoV-2 infection, and cellular immune responses contribute to protection against rechallenge with SARS-CoV-2. The findings suggest that relatively low antibody titres are sufficient for protection against SARS-CoV-2 in macaques, while higher antibody titres are required for treatment of SARS-CoV-2 infection.

NATURE (2021)

Article Medicine, General & Internal

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

A. C. Kalil et al.

Summary: Combination treatment with baricitinib plus remdesivir was superior to remdesivir alone in reducing recovery time and accelerating improvement in clinical status among patients with Covid-19, notably among those receiving high-flow oxygen or noninvasive ventilation. The combination was associated with fewer serious adverse events.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Review Medicine, Research & Experimental

Stem cell therapy in COVID-19: Pooled evidence from SARS-CoV-2, SARS-CoV, MERS-CoV and ARDS: A systematic review

Saniya Mahendiratta et al.

Summary: Through a systematic review, it was found that stem cells have the potential to reduce systemic inflammation and combat SARS-CoV-2. Despite the need for further research to validate their efficacy, MSCs may overcome clinical challenges faced by SARS-CoV-2 infected patients.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Review Medicine, General & Internal

Stem Cells Therapy for COVID-19: A Systematic Review and Meta-Analysis

Erfan Arabpour et al.

Summary: Despite challenges in COVID-19 vaccination, stem cell therapy shows significant effects in reducing mortality and morbidity rates in patients with COVID-19. Further large-scale studies are needed to confirm these results and establish a protocol for stem cell therapy to achieve the best clinical outcomes.

FRONTIERS IN MEDICINE (2021)

Review Cell & Tissue Engineering

Stem cell-based therapy for COVID-19 and ARDS: a systematic review

Gabriele Zanirati et al.

Summary: This study conducted a systematic review of 30 clinical studies on COVID-19 and ARDS treatment, with most studies utilizing MSCs for treatment. Findings suggest a positive impact of stem cell therapy on immunological and inflammatory processes in COVID-19 and ARDS patients, with no reported deaths causally linked to cell therapy. The results support the consideration of MSCs treatment as a potential candidate for adjuvant therapy in moderate-to-severe COVID-19 cases and compassionate use.

NPJ REGENERATIVE MEDICINE (2021)

Review Biochemistry & Molecular Biology

The signal pathways and treatment of cytokine storm in COVID-19

Lan Yang et al.

Summary: The COVID-19 pandemic is a global crisis with devastating effects, where immunopathology plays a crucial role in disease progression, particularly the cytokine storm which has a significant impact on prognosis. Understanding and targeting the pathways involved in cytokine storm could lead to more effective treatment strategies for COVID-19.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Review Cell Biology

Mesenchymal stem/stromal cell-based therapy: mechanism, systemic safety and biodistribution for precision clinical applications

Wei-Zhan Zhuang et al.

Summary: Mesenchymal stem/stromal cells (MSCs) are a promising resource for cell-based therapy due to their high immunomodulation ability and tropism towards inflamed and injured tissues. However, the lack of standardized methods to evaluate the safety, efficacy, and biodistribution of MSCs has been a major hindrance to their clinical application.

JOURNAL OF BIOMEDICAL SCIENCE (2021)

Letter Biochemistry & Molecular Biology

Prognostic value of lymphocyte count in severe COVID-19 patients with corticosteroid treatment

Chenyang Lu et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2021)

Article Medicine, General & Internal

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China

Dawei Wang et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Emergency Medicine

Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis

Brandon Michael Henry et al.

AMERICAN JOURNAL OF EMERGENCY MEDICINE (2020)

Article Cardiac & Cardiovascular Systems

Allogeneic cardiosphere-derived cells (CAP-1002) in critically ill COVID-19 patients: compassionate-use case series

Siddharth Singh et al.

BASIC RESEARCH IN CARDIOLOGY (2020)

Review Microbiology

The Innate Immune System: Fighting on the Front Lines or Fanning the Flames of COVID-19?

Julia L. McKechnie et al.

CELL HOST & MICROBE (2020)

Letter Medicine, General & Internal

Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State

Matt Arentz et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Medicine, General & Internal

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

Safiya Richardson et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Immunology

Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia

Fan Wang et al.

JOURNAL OF INFECTIOUS DISEASES (2020)

Letter Medicine, General & Internal

COVID-19: consider cytokine storm syndromes and immunosuppression

Puja Mehta et al.

LANCET (2020)

Editorial Material Multidisciplinary Sciences

Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients

Yonggang Zhou et al.

NATIONAL SCIENCE REVIEW (2020)

Article Medicine, General & Internal

Covid-19 in Critically Ill Patients in the Seattle Region - Case Series

Pavan K. Bhatraju et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Infectious Diseases

Lymphopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A systemic review and meta-analysis

Qianwen Zhao et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)

Article Biochemistry & Molecular Biology

Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity

Carolyn Rydyznski Moderbacher et al.

Article Infectious Diseases

Dynamic changes in peripheral blood lymphocyte subsets in adult patients with COVID-19

Zhifeng Deng et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)

Article Immunology

Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease Severity

Glen Huang et al.

EMERGING INFECTIOUS DISEASES (2020)

Review Cell & Tissue Engineering

Mesenchymal Stem Cell-Based Therapy of Inflammatory Lung Diseases: Current Understanding and Future Perspectives

C. Randall Harrell et al.

STEM CELLS INTERNATIONAL (2019)

Article Cell & Tissue Engineering

Adipose Tissue-Derived Mesenchymal Stem Cells Have a Heterogenic Cytokine Secretion Profile

Yongkang Wu et al.

STEM CELLS INTERNATIONAL (2017)

Review Immunology

How regulatory T cells work

Dario A. A. Vignali et al.

NATURE REVIEWS IMMUNOLOGY (2008)